Polypeptide having heparanase activity

Details Polypeptide having heparanase activity Polypeptide having heparanase activity

2001-02-06

2010-02-23

Hutson, Richard G (Department: 1652)

Chemistry: molecular biology and microbiology

Enzyme , proenzyme; compositions thereof; process for...

Hydrolase

C435S183000, C435S195000, C435S200000, C435S201000, C424S094600

Reexamination Certificate

active

07666651

ABSTRACT:
A polynucleotide (hpa) encoding a polypeptide having heparanase activity, vectors including same, genetically modified cells expressing heparanase, a recombinant protein having heparanase activity and antisense oligonucleotides and constructs for modulating heparanase expression.

REFERENCES:
patent: 2295323 (1942-09-01), Armstrong
patent: 4117841 (1978-10-01), Perrotta et al.
patent: 4455296 (1984-06-01), Hansen et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4859581 (1989-08-01), Nicholson et al.
patent: 4882318 (1989-11-01), Vlodavsky et al.
patent: 4937747 (1990-06-01), Koller
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5129877 (1992-07-01), Gallo et al.
patent: 5145679 (1992-09-01), Hinson
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5206223 (1993-04-01), Vlodavsky et al.
patent: 5332812 (1994-07-01), Nicolson et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5360735 (1994-11-01), Weinshank et al.
patent: 5362641 (1994-11-01), Fufs et al.
patent: 5399351 (1995-03-01), Leshchiner et al.
patent: 5474983 (1995-12-01), Kuna et al.
patent: 5550116 (1996-08-01), Lormeau et al.
patent: 5571506 (1996-11-01), Regan et al.
patent: 5580862 (1996-12-01), Rosen et al.
patent: 5589604 (1996-12-01), Drohan et al.
patent: 5600366 (1997-02-01), Schulman
patent: 5602095 (1997-02-01), Pastan et al.
patent: 5618709 (1997-04-01), Gewirtz et al.
patent: 5656595 (1997-08-01), Schweighoffer et al.
patent: 5667501 (1997-09-01), Fowler et al.
patent: 5688679 (1997-11-01), Powell
patent: 5700671 (1997-12-01), Prieto et al.
patent: 5714345 (1998-02-01), Clark
patent: 5716817 (1998-02-01), Tornell
patent: 5736137 (1998-04-01), Anderson et al.
patent: 5739115 (1998-04-01), Fugedi et al.
patent: 5799276 (1998-08-01), Komissarchik et al.
patent: 5799311 (1998-08-01), Agrawal et al.
patent: 5830759 (1998-11-01), Chang et al.
patent: 5859660 (1999-01-01), Perkins et al.
patent: 5859929 (1999-01-01), Zhou et al.
patent: 5917830 (1999-06-01), Chen et al.
patent: 5962321 (1999-10-01), Gough et al.
patent: 5968822 (1999-10-01), Pecker et al.
patent: 5997863 (1999-12-01), Zimmermann et al.
patent: 6020931 (2000-02-01), Bilbrey et al.
patent: 6140552 (2000-10-01), Deboer et al.
patent: 6153187 (2000-11-01), Yacoby-Zeevi
patent: 6177545 (2001-01-01), Pecker et al.
patent: 6190875 (2001-02-01), Ben-Artzi et al.
patent: 6226792 (2001-05-01), Goiffon et al.
patent: 6230151 (2001-05-01), Agrawal et al.
patent: 6242238 (2001-06-01), Freeman et al.
patent: 6307965 (2001-10-01), Aggarwal et al.
patent: 6314420 (2001-11-01), Lang et al.
patent: 6348344 (2002-02-01), Ayal-Hershkovitz et al.
patent: 6387643 (2002-05-01), Heinrikson et al.
patent: 6423312 (2002-07-01), Yacoby-Zeevi
patent: 6426209 (2002-07-01), Ayal-Hershkovitz et al.
patent: 6475763 (2002-11-01), Ayal-Hershkovitz et al.
patent: 6531129 (2003-03-01), Pecker et al.
patent: 6562950 (2003-05-01), Peretz et al.
patent: 6664105 (2003-12-01), Pecker et al.
patent: 6699672 (2004-03-01), Pecker et al.
patent: 6790658 (2004-09-01), Pecker et al.
patent: 6798658 (2004-09-01), Takedomi et al.
patent: 6800441 (2004-10-01), Pecker et al.
patent: 6946131 (2005-09-01), Peretz et al.
patent: 6960471 (2005-11-01), Pecker et al.
patent: 6986996 (2006-01-01), Pecker et al.
patent: 2001/0006630 (2001-07-01), Yacobi-Zeevi et al.
patent: 2002/0068061 (2002-06-01), Peretz et al.
patent: 2002/0088019 (2002-07-01), Yacobi-Zeevi et al.
patent: 2002/0102560 (2002-08-01), Pecker et al.
patent: 2002/0114801 (2002-08-01), Pecker et al.
patent: 2002/0168749 (2002-11-01), Pecker et al.
patent: 2002/0194625 (2002-12-01), Zcharia et al.
patent: 2003/0031660 (2003-02-01), Yacobi-Zeevi et al.
patent: 2003/0068806 (2003-04-01), Ayal-Hershkovitz et al.
patent: 2003/0161823 (2003-08-01), Ilan et al.
patent: 2003/0163836 (2003-08-01), Garofalo et al.
patent: 2003/0170860 (2003-09-01), Pecker et al.
patent: 2003/0181687 (2003-09-01), Peretz et al.
patent: 2003/0190737 (2003-10-01), Pecker et al.
patent: 2003/0217375 (2003-11-01), Zcharia et al.
patent: 2003/0236215 (2003-12-01), Pecker et al.
patent: 2004/0063135 (2004-04-01), Pecker et al.
patent: 2004/0142427 (2004-07-01), Pecker et al.
patent: 2004/0146497 (2004-07-01), Ilan et al.
patent: 2004/0146925 (2004-07-01), Pecker et al.
patent: 2004/0213789 (2004-10-01), Yacobi-Zeevi et al.
patent: 2005/0260187 (2005-11-01), Ilan et al.
patent: 2006/0008892 (2006-01-01), Yacobi-Zeevi et al.
patent: 2006/0269552 (2006-11-01), Yacobi-Zeevi et al.
patent: 735116 (2001-06-01), None
patent: 768820 (2004-01-01), None
patent: 0254067 (1988-01-01), None
patent: 0998569 (2000-05-01), None
patent: 133264 (2001-04-01), None
patent: WO 88/01280 (1988-02-01), None
patent: WO 91/02977 (1991-03-01), None
patent: WO 91/19197 (1991-12-01), None
patent: WO 92/01003 (1992-01-01), None
patent: WO 95/04158 (1995-02-01), None
patent: WO 95/04518 (1995-02-01), None
patent: WO 97/11684 (1997-04-01), None
patent: WO 97/27327 (1997-07-01), None
patent: WO 98/03638 (1998-01-01), None
patent: WO 98/46258 (1998-10-01), None
patent: WO 99/11798 (1999-03-01), None
patent: WO 99/18852 (1999-04-01), None
patent: WO 99/21975 (1999-05-01), None
patent: WO 99/40207 (1999-08-01), None
patent: WO 99/48478 (1999-09-01), None
patent: WO 99/57153 (1999-11-01), None
patent: WO 99/57244 (1999-11-01), None
patent: WO 00/03036 (2000-01-01), None
patent: WO 00/25817 (2000-05-01), None
patent: WO 00/52149 (2000-09-01), None
patent: WO 00/52178 (2000-09-01), None
patent: WO 01/00643 (2001-01-01), None
patent: WO 02/19962 (2002-03-01), None
patent: WO 02/32283 (2002-04-01), None
patent: WO 03/006645 (2003-01-01), None
patent: WO 2004/108065 (2004-12-01), None
Ngo et al., Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox, in The Protein Folding Problem and Tertiary Structure Prediction, 1994, Merz et al. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.
H. Guo et al., “Protein Tolerance to Random Amino Acid Change”, PNAS 101(25):9205-9210, Jun. 2004.
Flanagan et al. “Potent and Selective Gene Inhibition Using Antisense Oligodeoxynucleotides”, Molecular and Cellular Biochemistry, 172: 213-225, 1997.
Frederiksen et al. “Antibiotic Treatment of Initial Colonization withPseudomonas aeruginosaPostpones Chronic Infection and Prevents Deterioraton of Pulmonary Function in Cystic Fibrosis”, Pediatr. Pulmonol. 23(5): 330-335, 1997. Abstract.
Frederiksen et al. Changing Epidemiology ofPseudomonas aeruginosaInfection in Danish Cystic Fibrosis Patients (1974.
Freeman et al. “A Rapid Quantitative Assay for the Detection of Mammalian Heparanase Activity”, Biochemical Journal, 325: 229.
Freeman et al. “Evidence That Platelet and Tumor Heparanases Are Similar Enzymes”, Biochem J., 342: 361.
Freeman et al. “Human Platelet Heparanase: Purification, Characterization and Catalytic Activity”, Biochem. J., 330: 1341.
Friedman et al. Regulated Expression of Homeobox Genes Msx.
Gabriel et al. “In Vitro Adherence ofPseudomonas aeruginosato Four Intraocular Lenses”, J. Cataract Refract Surg., 24: 124.
Gantt et al. Cell Adhesion to A Motif Shared by the Malaria Circumsporozoite Protein and Thrombospondin Is Mediated by Its Glycosminoglycan.
Garner “Epidermal Regulation of Dermal Fibroblast Activity”, Plast. Reconstr. Surg., 102(1):135.
Gewirtz et al. “Facilitating Oligonucleotide Delivery: Helping Antisense Deliver on Its Promise”, Proc. Natl. Acad. Sci. USA, 93: 3161.
Gewirtz et al. “Nucleic Acid Therapeutics: State of the Art and Future Prospects”, Blood, 92(3): 712.
Ghani et al. “Ceftazidime, Gentamicin, and Rifampicin, in Combination, Kill Biofilms of MucoidPseudomonas aeruginosa”, Can. J. Microbiol., 43(11): 999.
Haisma et al. “Construction and Characterization of A Fusion Protein of Single-Chain Anti-Carcinoma Antibody 323/A3 and Human Beta-Glucuronidase”.
Hammer et al. “Spontaneous Inflammatory Disease in Transgenic Rats Expressing HLA-B27 and Human ?2m: An Animal Model of HLA

Affiliated with

Also associated with

Rating

Polypeptide having heparanase activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide having heparanase activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide having heparanase activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4207858